Goodluck India Bonus Issue

Goodluck India Capacity Expansion: ₹80 Cr Investment

Goodluck India's subsidiary Goodluck Defence and Aerospace approved adding Aerospace Components as a new line of business. The estimated investment is Rs 80 Crore, within a previously approved capital outlay.

Value

₹80.00 Cr

Goodluck India Other Announcement

Goodluck India appointed Raj Kaushik & Associates as Cost Auditors for a 5-month term effective 28 Oct 2026. This is a routine statutory appointment with no financial impact.

Goodluck India Q2 FY27 Results: Net Profit ₹50.7 Cr, Up 19.0% YoY

Goodluck India Ltd reported revenue from operations of ₹1,363 Cr (+37.5% YoY) and net profit of ₹50.7 Cr (+19.0% YoY) for Q2 FY27.

Key figure

Net profit ₹50.7 Cr · +19.0% YoY

Goodluck India Management Change

Goodluck India disclosed the death of its cost auditor, Mr. Surender Rai Kapur, under Regulation 30. The company will appoint a new cost auditor to fill the casual vacancy.

Goodluck India Board Meeting Date

Goodluck India Limited scheduled a board meeting for October 28, 2026, to consider and approve the company's unaudited financial results for the quarter ended September 2026.

Goodluck India Other Announcement

Goodluck India Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).

Shreeji Global FMCG Bonus Issue

Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.

Concord Biotech Bonus Issue

Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.

Anlon Technology Solutions Bonus Issue

Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.

Concord Biotech Bonus Issue

Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.

Titan Biotech Bonus Issue

Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.

Utssav CZ Gold Jewels Bonus Issue

Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.